Overview of Telma-H
| Property | Description |
|---|---|
| Active Ingredients | Telmisartan, Hydrochlorothiazide |
| Form | Oral Tablet |
| Pharmacological Class | ARB + Thiazide Diuretic (Antihypertensive) |
| General Purpose | Management of high blood pressure (Hypertension) |
| Origin | Synthetic |
1. Defining the Telma-H Combination: Type and Classification
Telma-H is a synthetic, prescription-only medication administered as an Oral Tablet that is classified as a dual-agent Antihypertensive Agent. The medication is a Fixed-Dose Combination Product, meaning it systematically integrates two distinct active compounds from different pharmacological classes into a single solid oral form. This combination is clinically recognized for achieving successful blood pressure goals in a single administration.
The medication's primary utility is to provide consistent normalization of arterial pressure, a strategy used in clinical management, particularly when single-agent therapy proves insufficient.
2. Composition and Drug Form: Telmisartan and Hydrochlorothiazide
The core of the medication’s identity lies in its two synthetic active ingredients: the International Nonproprietary Names (INN) Telmisartan and Hydrochlorothiazide (HCTZ). Telmisartan is scientifically known as a non-peptide Angiotensin II Receptor Blocker (ARB), while Hydrochlorothiazide belongs specifically to the thiazide diuretic class, commonly referred to as a “water pill.”
The final dosage form is an Oral Tablet, created by embedding these two active substances within a pharmaceutical excipient matrix suitable for ingestion. This fixed-dose formulation ensures that both the mechanism targeting vascular tone and the mechanism controlling fluid volume are simultaneously introduced into the body.
3. The Dual Action Principle and General Purpose
The overall general purpose of Telma-H is the effective management of hypertension, achieved through its combined therapeutic principle. This dual action is rooted in Telmisartan's role in blocking the action of a hormone that naturally causes blood vessels to constrict, thus promoting their relaxation and widening. Concurrently, Hydrochlorothiazide increases the excretion of excess salt and water by the kidneys, which serves to reduce the total fluid volume circulating in the body. This complementary effect on both vascular resistance and blood volume is central to the drug's utility in normalizing arterial pressure, a key step in reducing the risk of cardiovascular events.
Regulatory References
